Английская Википедия:Filaminast

Материал из Онлайн справочника
Версия от 15:20, 7 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|Chemical compound}} {{Drugbox | IUPAC_name = [(''E'')-1-(3-Cyclopentyloxy-4-methoxyphenyl)ethylideneamino] carbamate | image = Filaminast.svg <!--Clinical data--> | tradename = | pregnancy_category = | legal_status = Development terminated | routes_of_administration = <!--Pharmacokinetic data--> | bioavailability = | metabolism = | elimination_half-life = | excret...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

Filaminast (code name WAY-PDA 641)[1] was a drug candidate developed by Wyeth-Ayerst.[2]Шаблон:Rp It is a phosphodiesterase 4 inhibitor (PDE4 inhibitor) and an analog of rolipram, which served as a prototype molecule for several development efforts.[3][4]Шаблон:Rp It was discontinued after a Phase II trial showed that its therapeutic window was too narrow; it could not be dosed high enough without causing significant side effects (nausea and vomiting), which was a problem with the rolipram class of molecules.[4]Шаблон:Rp

See also

References

Шаблон:Reflist

Шаблон:Phosphodiesterase inhibitors Шаблон:Drugs for obstructive airway diseases